BeStock  

Hutchmed (China) HCM

US equityMarket cap rank #2625Drug Manufacturers - Specialty & Generic
$14.31 +$0.11 (+0.77%)
Pre-market · Oct 6, 6:50 am ET · After hours $14.31 0.00%
Open$14.14
Prev close$14.20
Day range$13.90 – $14.34
Volume65.1K
Market cap$2.50B
P/E (TTM)178.9
Dividend yield–

Earnings

Average move on report day±5.7%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+14.7%
Worst reaction-9.0%

Stock move on the day after each report

-7.2%2020/Q4+14.7%2021/Q2-6.9%2021/Q4-7.7%2022/Q2+5.3%2022/Q4-4.4%2023/Q2-4.9%2023/Q4+8.0%2024/Q2+8.2%2024/Q4-9.0%2025/Q2+1.5%2025/Q4-5.4%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q230 Jul 2026Pre Market±33.8%-5.44%Within range
2025/Q45 Mar 2026Pre Market–+1.50%–
2025/Q27 Aug 2025Pre Market±14.8%-9.01%Within range
2024/Q419 Mar 2025Pre Market±11.0%+8.23%Within range
2024/Q231 Jul 2024Pre Market±23.7%+8.00%Within range
2023/Q428 Feb 2024Pre Market–-4.88%–
2023/Q231 Jul 2023Pre Market±21.0%-4.42%Within range
2022/Q428 Feb 2023None±18.8%+5.35%Within range
2022/Q21 Aug 2022Pre Market±27.8%-7.65%Within range
2021/Q43 Mar 2022Pre Market±16.6%-6.95%Within range
2021/Q228 Jul 2021Pre Market±19.7%+14.71%Within range
2020/Q44 Mar 2021Pre Market–-7.16%–
2020/Q230 Jul 2020Pre Market–-3.05%–
2019/Q43 Mar 2020Pre Market–-0.88%–
2019/Q230 Jul 2019None–+0.39%–
2018/Q411 Mar 2019None–+3.94%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By business line

  • Oncology/Immunology$285.54M 52.1%
  • Other Ventures$262.97M 47.9%

By region

  • People’s Republic of China (PRC)$407.45M 74.3%
  • US and Others$141.06M 25.7%

Discussion

No comments yet — be the first to weigh in on HCM.

Leave a comment

Scroll to Top